Prescribing and monitoring non-biological DMARDs

The British Society for Rheumatology and British Health Professionals in Rheumatology recently updated their guidance on prescribing and monitoring non-biological disease-modifying antirheumatic drugs (DMARDs) for patients with rheumatic disease. This article provides an overview of the main recommendations of the new guideline.

Read the full article.

Add yours ↓
Web design and marketing agency Leamington Spa